Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Aging ; 38: 164-175, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26827654

ABSTRACT

Aging is associated with decreased neurogenesis in the hippocampus and diminished hippocampus-dependent cognitive functions. Expression of bone morphogenetic protein 4 (BMP4) increases with age by more than 10-fold in the mouse dentate gyrus while levels of the BMP inhibitor, noggin, decrease. This results in a profound 30-fold increase in phosphorylated-SMAD1/5/8, the effector of canonical BMP signaling. Just as observed in mice, a profound increase in expression of BMP4 is observed in the dentate gyrus of humans with no known cognitive abnormalities. Inhibition of BMP signaling either by overexpression of noggin or transgenic manipulation not only increases neurogenesis in aging mice, but remarkably, is associated with a rescue of cognitive deficits to levels comparable to young mice. Additive benefits are observed when combining inhibition of BMP signaling and environmental enrichment. These findings indicate that increased BMP signaling contributes significantly to impairments in neurogenesis and to cognitive decline associated with aging, and identify this pathway as a potential druggable target for reversing age-related changes in cognition.


Subject(s)
Aging/genetics , Aging/psychology , Bone Morphogenetic Protein 4/genetics , Bone Morphogenetic Protein 4/metabolism , Cognition , Neurogenesis , Signal Transduction/genetics , Signal Transduction/physiology , Aging/pathology , Aging/physiology , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cognition Disorders/genetics , Cognition Disorders/therapy , Dentate Gyrus/metabolism , Gene Expression , Hippocampus/pathology , Hippocampus/physiopathology , Humans , Male , Mice, Inbred C57BL , Molecular Targeted Therapy
2.
J Neurosci ; 32(48): 17211-24, 2012 Nov 28.
Article in English | MEDLINE | ID: mdl-23197713

ABSTRACT

Hypothalamic neural circuits are known to regulate energy homeostasis and feeding behavior, but how these circuits are established during development is not well understood. Here we report that embryonic neural progenitors that express the transcription factor OLIG1 contribute neurons to the ventral hypothalamus including the arcuate nucleus (ARH), a center that regulates feeding behavior. Ablation of bone morphogenetic protein receptor 1a (BMPR1A) in the OLIG1 lineage resulted in hypophagia, hypoglycemia, and weight loss after the second postnatal week with death by week 4. Differentiation and specification of inhibitory hypothalamic neurons contributing to melanocortin and dopaminergic systems were abnormal in the BMPR1A-deficient ARH. Although the hypophagia promoted expression of the orexigenic neuropeptide agouti related protein (AgRP) in the BMPR1A-deficient ARH, there was a profound decrease of AgRP(+) axonal terminals in the mutant ARH targets including dorsomedial and paraventricular hypothalamic nuclei. Projection of AgRP(+) neurons to these nuclei is known to be regulated by leptin. Leptin injection in neonatal mice increased bone morphogenic protein (BMP) signaling in the ventral hypothalamus, and blocking BMP signaling prevented leptin-induced neurite outgrowth in ARH explant cultures. These findings suggest that BMPR1A signaling is critical for postnatal establishment of leptin-responsive orexigenic fibers from ARH to multiple hypothalamic nuclei. More generally these observations indicate that BMPR1A signaling regulates postnatal establishment of OLIG1 lineage-derived ARH neuronal circuits that are critical for leptin-mediated feeding behavior.


Subject(s)
Bone Morphogenetic Protein Receptors, Type I/genetics , Feeding Behavior/physiology , Hypothalamus/metabolism , Nerve Net/metabolism , Neurons/metabolism , Agouti-Related Protein/metabolism , Animals , Bone Morphogenetic Protein Receptors, Type I/metabolism , Cell Proliferation , Feeding Behavior/drug effects , Hypothalamus/drug effects , Leptin/pharmacology , Mice , Mice, Knockout , Nerve Net/drug effects , Neural Pathways/drug effects , Neural Pathways/metabolism , Neurons/drug effects , Neuropeptide Y/metabolism , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...